# Emergent Product Development Gaithersburg Inc.

Canonical: https://abierto.us/vendors/emergent-product-development-gaithersburg-inc-cnpvcr8dk7m8

- UEI: CNPVCR8DK7M8
- CAGE: 057Y1
- Parent: Emergent Biosolutions Inc.
- Location: Gaithersburg, MD
- Awards in window: 2 (2 transactions), $76,764,078 obligated, June 26, 2026 to August 18, 2026

## Awarding agencies

- Office of Assistant Secretary for Preparedness and Response: 2 awards, $76,764,078

## Industries

- 325414 Biological Product (except Diagnostic) Manufacturing: $52,780,490
- 541711 Professional, Scientific, and Technical Services: $23,983,588

## Competition

- Full and Open Competition: 2 awards

## Largest awards

- 75A50119C00071 (definitive contract): $52,780,490, Aspr/Orm-Sns. Acam2000, Smallpox (Vaccinia) Vaccine, Live (Acam). https://www.usaspending.gov/award/CONT_AWD_75A50119C00071_7505_-NONE-_-NONE-/
- HHSO100201600030C (definitive contract): $23,983,588, Barda - Aspr / Daappo / Barda DCMA. EO14042 Emergent AV7909 Anthrax Vaccine. https://www.usaspending.gov/award/CONT_AWD_HHSO100201600030C_7505_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/emergent-product-development-gaithersburg-inc-cnpvcr8dk7m8.